MICRO-SURG: Subgingival Microbiome in Peri-Implantitis, Regenerative, and Resective Periodontal Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity Hospital Muenster

About this trial

This clinical study investigates how the subgingival microbiome changes after three different periodontal and peri-implant surgical procedures: (1) resective periodontal surgery, (2) regenerative periodontal surgery, and (3) peri-implantitis surgery. The aim is to characterize microbial shifts associated with these commonly used surgical treatments and to determine whether the type of surgery influences the recovery or disruption of the subgingival ecosystem. Adult patients with periodontitis or peri-implantitis will receive the procedure indicated for their condition. Subgingival plaque samples will be collected at baseline and at defined postoperative follow-up intervals. Microbiome analysis will be performed using next-generation sequencing (NGS), and microbial changes will be evaluated with the Subgingival Microbial Dysbiosis Index (SMDI). Insights from this study may help improve prevention, diagnostics, and treatment strategies for periodontal and peri-implant diseases.

Eligibility criteria

Qualifiers

Age 18 years or older

Confirmed diagnosis of Peri-implantitis (for the peri-implantitis surgery arm), or Stage III/IV periodontitis (for the periodontal surgery arms)

Indication for surgical therapy corresponding to the assigned study arm

Ability to understand the study procedures and provide written informed consent

Disqualifiers

Systemic conditions contraindicating oral surgical procedures

Severe systemic diseases (e.g., uncontrolled diabetes mellitus, immunosuppressive disorders)

Use of systemic antibiotics within the previous 3 months

Active COVID-19 infection at the time of surgery

Trial design

Treatments tested in this trial

  • Resective Periodontal Surgery
  • Regenerative Periodontal Surgery
  • Surgical Peri-implantitis Therapy

Treatment groups

84 Participants
are divided into 3 treatment groups

Sponsors and collaborators